{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/b7ed13ff312447cfb2352f813400a3f7\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/b7ed13ff312447cfb2352f813400a3f7-ae66906d753bbbe6.gif","duration":589.74,"title":"Exploring the Hemio Platform for AML Diagnostics and Treatment Recommendations 🩺","description":"In this video, I walk you through our Hemio platform, focusing on how to upload patient reports and ensure accurate data extraction for myeloid malignancies. We emphasize the importance of validating information, particularly regarding TP53 mutations, and provide a transparent decision-making process for patient classification. Additionally, I highlight our risk stratification features and treatment recommendations, including clinical trial matching. I encourage you to engage with the platform and check the extracted data for accuracy. Your feedback is crucial as we continue to refine these features."}